Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Insulin mediator isolated from beef liver

Aug. 5, 1997

Alteon's pimagedine progresses to phase III

Aug. 4, 1997

Crinone approved in U.S. for additional indication

Aug. 4, 1997

Ergoset improves metabolism in healthy obese women

Aug. 4, 1997

Novartis reports new NPY antagonists with selectivity for Y5 receptors

Aug. 1, 1997

Clinical trial of Lipitor for the reduction of cholesterol in women

July 31, 1997

Acute and subchronic effects of SR-58611A on glucose tolerance in mice

July 31, 1997

Troglitazone approved in the U.K.

July 31, 1997

Phase I comparison of CCKA agonist and CCK-8 for effects on satiety

July 31, 1997

Antiobesity drug therapy

July 31, 1997

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...